bupranolol has been researched along with sr 59230a in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amend, A; Candelore, MR; Cascieri, MA; Deng, L; Guan, XM; Liu, Y; Newbold, R; Tota, L; Weber, AE | 1 |
| Atgié, C; Berlan, M; Carpéné, C; Fontana, E; Galitzky, J; Lafontan, M | 1 |
| Brawley, L; MacDonald, A; Shaw, AM | 1 |
| Horinouchi, T; Koike, K | 1 |
| Guibert, C; Ivorra, MD; Leblais, V; Marthan, R; Muller, B; Pourageaud, F | 1 |
| Brahmadevara, N; MacDonald, A; Shaw, AM | 1 |
| Ivorra, MD; Leblais, V; Marthan, R; Muller, B; Pourageaud, F | 1 |
| Doheny, HC; Lynch, CM; Morrison, JJ; Smith, TJ | 1 |
| Boccioletti, V; Cominacini, L; Evangelista, S; Garbin, U; Pasini, AF; Stranieri, C | 1 |
| Jóźwik, M; Kleszczewski, T; Modzelewska, B; Sulkowski, S | 1 |
10 other study(ies) available for bupranolol and sr 59230a
| Article | Year |
|---|---|
Potent and selective human beta(3)-adrenergic receptor antagonists.
Topics: Adipocytes; Adrenergic beta-Antagonists; Aminophenols; Animals; Binding, Competitive; CHO Cells; Cloning, Molecular; Cricetinae; Cyclic AMP; Humans; Ligands; Lipolysis; Macaca mulatta; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Structure-Activity Relationship; Sulfonamides | 1999 |
Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic beta-Agonists; Adult; Animals; Binding, Competitive; Biogenic Amines; Bupranolol; CHO Cells; Cricetinae; Dioxoles; Dogs; Ethanolamines; Female; Gene Expression; Guinea Pigs; Humans; Imidazoles; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Lipolysis; Male; Mammals; Mesocricetus; Norepinephrine; Octopamine; Oxygen Consumption; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Species Specificity | 1999 |
Beta 1-, beta 2- and atypical beta-adrenoceptor-mediated relaxation in rat isolated aorta.
Topics: Acetylcholine; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Aorta, Thoracic; Bupranolol; Dose-Response Relationship, Drug; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Pindolol; Propanolamines; Propranolol; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Substrate Specificity; Vasodilator Agents | 2000 |
Agonistic activity of SR59230A at atypical beta-adrenoceptors in guinea pig gastric fundus and duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Dose-Response Relationship, Drug; Duodenum; Gastric Fundus; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
Role of alpha-adrenergic receptors in the effect of the beta-adrenergic receptor ligands, CGP 12177, bupranolol, and SR 59230A, on the contraction of rat intrapulmonary artery.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding Sites; Bupranolol; Calcium; Dinoprost; Female; Male; Prazosin; Propanolamines; Pulmonary Artery; Rats; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Tritium; Vasoconstriction | 2004 |
ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Aorta, Thoracic; Binding Sites; Bupranolol; Cell Membrane; Cerebral Cortex; Dose-Response Relationship, Drug; Ethanolamines; Imidazoles; Male; Muscle, Smooth, Vascular; Phenylephrine; Pindolol; Prazosin; Propanolamines; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-3; Tritium; United Kingdom; Vasoconstriction | 2004 |
Comparison of the alpha-adrenoceptor-mediated effects of beta3-adrenoceptor ligands in rat pulmonary artery.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Dioxoles; Ethanolamines; In Vitro Techniques; Ligands; Male; Propanolamines; Pulmonary Artery; Rats; Rats, Wistar; Receptors, Adrenergic, beta-3; Vasodilation | 2005 |
Functional coupling of beta3-adrenoceptors and large conductance calcium-activated potassium channels in human uterine myocytes.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Bupranolol; Dose-Response Relationship, Drug; Electrophysiology; Ethanolamines; Female; Humans; In Vitro Techniques; Isometric Contraction; Membrane Potentials; Muscle Cells; Muscle Relaxation; Myometrium; Oxytocin; Peptides; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Propanolamines; Receptors, Adrenergic, beta-3; Uterine Contraction; Uterus | 2005 |
Effect of DL-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells.
Topics: Adrenergic beta-Antagonists; Antioxidants; Benzopyrans; Biotransformation; Bupranolol; Calcium; Cells, Cultured; Endothelial Cells; Enzyme Activation; Ethanolamines; Humans; Lipoproteins, LDL; Nadolol; Nebivolol; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Propanolamines; Receptors, Adrenergic, beta; Stereoisomerism; Superoxides | 2007 |
Myometrial Responses to Beta-Adrenoceptor Antagonists in Gynecological Malignancies.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Bupranolol; Endometrial Neoplasms; Ethanolamines; Female; Genital Neoplasms, Female; Humans; Myometrium; Ovarian Neoplasms; Propanolamines; Propranolol; Prospective Studies; Uterine Cervical Neoplasms; Uterine Contraction; Uterus | 2021 |